Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 5, Number 3—June 1999

Letter

Hepatitis C Virus RNA Viremia in Central Africa

Suggested citation for this article

To the Editor: Epidemiologic serosurveys have demonstrated high prevalence (6%-15%) of hepatitis C virus (HCV) infection in adults in sub-Saharan Africa (1-4). Although possible false-positive HCV serologic test results have been reported in Africa, HCV prevalence rates suggest a high rate of chronic infection among persons with anti-HCV antibodies (5,6). We have focused on HCV RNA infectivity of blood from donors attending the National Blood Center in Bangui, Central African Republic.

We prospectively tested all blood donors between February and April 1998 for serum anti-HCV antibodies by both an HCV third-generation enzyme-linked immunosorbent assay (ELISA) (Abbott HCV EIA 3.0 test, Abbott, Chicago, IL, USA), which was chosen as a reference test for immunoglobulin (Ig) G antibodies to HCV, and by a simple membrane immunoassay system (Ortho HCV Ab Quik Pack, Ortho Diagnostic Systems Inc., Tokyo, Japan) (7). Anti-HCV-positive serum samples were further subjected to qualitative detection of HCV RNA by reverse transcription-polymerase chain reaction (AMPLICOR-HCV, Roche Diagnostic Systems, Inc., Branchburg, NJ, USA) (8). Of 163 serum samples (mean age ± standard deviation, 30±8 years), 155 were from male blood donors, 83 (51%) from first-time donors, and 125 (77%) from donors in the recipient's family. Fifteen (9.2%; 95% confidence interval [CI] 5%-15%) samples contained IgG to HCV by ELISA. Of the ELISA-positive samples, 14 were positive by the Quik Pack assay (sensitivity, 93.0%); of the 148 remaining ELISA-negative samples, 147 were negative by the Quik Pack assay (specificity, 99.3%). The agreement between the results of the two methods was 98.7%. Of the 163 samples, 10 (6.1%; CI 95%: 3%-11%) were positive for HCV antibodies (by ELISA and rapid test) and for HCV RNA.

We confirmed a high prevalence of HCV-seropositivity among blood donors in Bangui and the subsequent high rate of HCV RNA viremic blood donations. To offset the major risk for transfusion-acquired HCV in Central Africa we recommend screening donated blood for anti-HCV. When laboratory facilities to perform ELISA are not available, the Quik Pack system, a simple reliable method for detecting anti-HCV antibodies in human serum that requires neither complex reagent preparation nor expensive instrumentation, could prove useful.

Nicole Cancré*, Gérard Grésenguet†, François-Xavier Mbopi-Kéou‡, Alain Kozemaka†, Ali Si Mohamed*, Mathieu Matta*, Jean-Jacques Fournel§, and Laurent Bélec*
Author affiliations: *Université Pierre et Marie Curie, Hôpital Broussais, Paris, France; †Centre National de Transfusion Sanguine, Bangui, République Centrafricaine; ‡London School of Hygiene and Tropical Medicine, London, United-Kingdom; and; §Hôpital de la Pitié-Salpêtrière, Paris, France

References

  1. Ndumbe PM, Skalsky J. Hepatitis C virus infection in different populations in Cameroon. Scand J Infect Dis. 1993;25:68992. DOIPubMed
  2. Xu LZ, Larzul D, Delaporte E, Bréchot C, Kremsdorf D. Hepatitis C virus genotype 4 highly prevalent in Central Africa (Gabon). J Gen Virol. 1994;75:23938. DOIPubMed
  3. Fretz C, Jeannel D, Stuyver L, Herve V, Lunel F, Boudifa A, HCV Infection in a rural population of Central African Republic (CAR): evidence for three additional subtypes of genotype 4. J Med Virol. 1995;47:4357. DOIPubMed
  4. Pawlotsky JM, Bélec L, Grésenguet G, Desforges L, Bouvier M, Duval J, High prevalence of hepatitis B, C and E markers in young sexually active adults from the Central African Republic. J Med Virol. 1995;46:26973. DOIPubMed
  5. Aceti A, Taliani D. Hepatitis C virus testing in African sera. Ann Intern Med. 1992;116:427.PubMed
  6. Callahan JD, Constantine NT, Kataaha P, Zhang X, Hyams KC, Bansal J. Second generation hepatitis C virus assays: performance when testing African sera. J Med Virol. 1993;41:358. DOIPubMed
  7. Kodama T, Ichiyama S, Sato K, Nada T, Nakashima N. Evaluation of a membrane filter assay system, Ortho HCV Ab Quik Pack, for detection of anti-hepatitis C virus antibody. J Clin Microbiol. 1998;36:143940.PubMed
  8. Young KKY. R. Resnick RM, Myers TW. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol. 1993;31:8826.PubMed

Suggested citation: Cancré N, Grésenguet G, Mbopi-Kéou F-X, Kozemaka A, Mohamed AS, Matta M, et al. Hepatitis C Virus RNA Viremia in Central Africa [letter]. Emerg Infect Dis [serial on the Internet]. 1999, Jun [date cited]. Available from http://wwwnc.cdc.gov/eid/article/5/3/99-0330.htm Cancré

DOI: 10.3201/eid0503.990330

Related Links

Top of Page

Table of Contents – Volume 5, Number 3—June 1999

Comments to the EID Editors

Please contact the EID Editors via our Contact Form.

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO